72 related articles for article (PubMed ID: 448116)
21. Partial restoration of the lipopolysaccharide-induced proliferative response in splenic B cells from C3H/HeJ mice.
Kuus-Reichel K; Ulevitch RJ
J Immunol; 1986 Jul; 137(2):472-7. PubMed ID: 3487572
[TBL] [Abstract][Full Text] [Related]
22. [Immunomodulating activity of beta-heptylglycoside-muramyldipeptide in vivo].
Kaliuzhin OV; Zakharova NS; Britsina MV; Zemliakov AE; Kaliuzhin VV
Biull Eksp Biol Med; 1999 Nov; 128(11):553-4. PubMed ID: 10640246
[No Abstract] [Full Text] [Related]
23. Monophosphoryl lipid A-induced immune enhancement of Brucella abortus salt-extractable protein and lipopolysaccharide vaccines in BALB/c mice.
Tabatabai LB; Pugh GW; Stevens MG; Phillips M; McDonald TJ
Am J Vet Res; 1992 Oct; 53(10):1900-7. PubMed ID: 1456539
[TBL] [Abstract][Full Text] [Related]
24. [The cytoplasmic membranes and lipopolysaccharide of Escherichia coli as immunostimulants].
Ivanova E; Slavcheva E; Gumpert I; Georgiev D; Stoianova P
Acta Microbiol Bulg; 1988; 23():69-77. PubMed ID: 3073648
[No Abstract] [Full Text] [Related]
25. Distinctive immunomodulatory effects of endotoxin and nontoxic lipopolysaccharide derivatives in lymphoid cell cultures.
Friedman H; Blanchard DK; Newton C; Klein T; Stewart W; Keler T; Nowotny A
J Biol Response Mod; 1987 Dec; 6(6):664-77. PubMed ID: 2453617
[TBL] [Abstract][Full Text] [Related]
26. Comparative studies on adjuvanticity of Klebsiella O3 lipopolysaccharide and its lipid A and polysaccharide fractions.
Kato N; Kido N; Ohta M; Naito S
Immunology; 1985 Feb; 54(2):317-24. PubMed ID: 3881339
[TBL] [Abstract][Full Text] [Related]
27. Immunologic activity of lipopolysaccharides released from macrophages after the uptake of intact E. coli in vitro.
Duncan RL; Hoffman J; Tesh VL; Morrison DC
J Immunol; 1986 Apr; 136(8):2924-9. PubMed ID: 3514750
[TBL] [Abstract][Full Text] [Related]
28. The adjuvant properties of a nontoxic monophosphoryl lipid A in hyporesponsive and aging mice.
Tomai MA; Solem LE; Johnson AG; Ribi E
J Biol Response Mod; 1987 Apr; 6(2):99-107. PubMed ID: 3585413
[TBL] [Abstract][Full Text] [Related]
29. Restoration of humoral immunity in vitro in immunodeficient aging mice by C8-derivatized guanine ribonucleosides.
Goodman MG; Weigle WO
J Immunol; 1985 Jun; 134(6):3808-11. PubMed ID: 3872903
[TBL] [Abstract][Full Text] [Related]
30. [Sensitivity of immunocompetent cells to a hormonal signal in the presence of mitogen].
Shirshev SV
Biull Eksp Biol Med; 1993 May; 115(5):497-9. PubMed ID: 8043832
[TBL] [Abstract][Full Text] [Related]
31. Lipopolysaccharide-induced immunomodulation of the generation cell-mediated cytotoxicity. II. Evidence for the involvement of a regulatory B lymphocyte.
Vallera DA; Gamble CE; Schmidtke JR
J Immunol; 1980 Feb; 124(2):641-9. PubMed ID: 6444315
[No Abstract] [Full Text] [Related]
32. A comparison of the immunomodulating properties of two forms of monophosphoryl lipid A analogues.
Johnson AG; Tomai MA; Chen YF; Odean M
J Immunother (1991); 1991 Dec; 10(6):398-404. PubMed ID: 1768673
[TBL] [Abstract][Full Text] [Related]
33. Biological activities of the lipopolysaccharide and lipid A from Acinetobacter calcoaceticus.
Brade H; Galanos C
J Med Microbiol; 1983 May; 16(2):211-4. PubMed ID: 6842571
[No Abstract] [Full Text] [Related]
34. Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsion.
Baldwin SL; Shaverdian N; Goto Y; Duthie MS; Raman VS; Evers T; Mompoint F; Vedvick TS; Bertholet S; Coler RN; Reed SG
Vaccine; 2009 Oct; 27(43):5956-63. PubMed ID: 19679214
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of lipopolysaccharide-mediated activation of neutrophils with monosaccharide derivatives of lipid A.
Lam C; Basalka E; Schütze E; Walzl H
Prog Clin Biol Res; 1987; 236A():427-35. PubMed ID: 3615442
[No Abstract] [Full Text] [Related]
36. Lipopolysaccharide (LPS) regulation of the immune response: LPS influence on oral tolerance induction.
Michalek SM; Kiyono H; Wannemuehler MJ; Mosteller LM; McGhee JR
J Immunol; 1982 May; 128(5):1992-8. PubMed ID: 6460815
[No Abstract] [Full Text] [Related]
37. Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene.
O'Brien AD; Rosenstreich DL; Scher I; Campbell GH; MacDermott RP; Formal SB
J Immunol; 1980 Jan; 124(1):20-4. PubMed ID: 6985638
[No Abstract] [Full Text] [Related]
38. LPS regulation of the immune response: Bacteroides endotoxin induces mitogenic, polyclonal, and antibody responses in classical LPS responsive but not C3H/HeJ mice.
Wannemuehler MJ; Michalek SM; Jirillo E; Williamson SI; Hirasawa M; McGhee JR
J Immunol; 1984 Jul; 133(1):299-305. PubMed ID: 6202784
[TBL] [Abstract][Full Text] [Related]
39. [The effect of bone marrow hexapeptides (myelopeptides) on antibody formation and pain sensitivity in mice and dependence of these effects on naloxone].
Metaksa EE; Zakharova LA; Koptelov OV; Koroleva NA; Ianovskiĭ OG
Biull Eksp Biol Med; 1995 Apr; 119(4):413-6. PubMed ID: 7620142
[No Abstract] [Full Text] [Related]
40. Endotoxin (LPS) stimulates in vitro migration of macrophages from LPS-resistant mice but not from LPS-sensitive mice.
Verghese MW; Snyderman R
J Immunol; 1982 Feb; 128(2):608-13. PubMed ID: 7054291
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
